Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention

Nephrology

Volumn 15, Issue 2, 2010, Pages 165-170

  Kandula, Praveen ^a   Shah, Ravish ^a   Singh, Nishith ^a   Markwell, Stephen J ^a   Bhensdadia, Nishant ^a   Navaneethan, Sankar D ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute kidney failure; Contrast medium; Contrast nephropathy; Coronary disease; Statin

Indexed keywords

ATORVASTATIN; CREATININE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SCORING SYSTEM; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CONTRAST MEDIA; CREATININE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77749302183     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01204.x     Document Type: Article

References (30)

1. McCullough PA. Contrast-induced acute kidney injury. J. Am. Coll. Cardiol. 2008 51 : 1419 1428.
2. Dangas G, Iakovou I, Nikolsky E et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am. J. Cardiol. 2005 95 : 13 19.
3. Marenzi G, Lauri G, Assanelli E et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. 2004 44 : 1780 1785.
4. Subramanian S, Tumlin J, Bapat B et al. Economic burden of contrast-induced nephropathy: Implications for prevention strategies. J. Med. Econ. 2007 10 : 119 134.
5. Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002 105 : 2259 2264.
6. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996 275 : 1489 1494.
7. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 2002 39 : 930 936.
8. Katholi RE, Woods WT Jr., Taylor GJ et al. Oxygen free radicals and contrast nephropathy. Am. J. Kidney Dis. 1998 32 : 64 71.
9. Solomon R. Radiocontrast-induced nephropathy. Semin. Nephrol. 1998 18 : 551 557.
10. Persson PB, Tepel M. Contrast medium-induced nephropathy: The pathophysiology. Kidney Int. Suppl. 2006 100 : S8 10.
11. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann. Intern. Med. 2008 148 : 284 294.
12. Kshirsagar AV, Poole C, Mottl A et al. N-Acetylcysteine for the prevention of radiocontrast-induced nephropathy: A meta-analysis of prospective controlled trials. J. Am. Soc. Nephrol. 2004 15 : 761 769.
13. Zhou MS, Schuman IH, Jaimes EA, Raij L. Renoprotection by statins is linked to a decrease in renal oxidative stress,TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am. J. Physiol. Renal. Physiol. 2008 295 : F53 59.
14. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal outcomes: A meta-analysis. J. Am. Soc. Nephrol. 2006 17 : 2006 2016.
15. Navaneethan SD, Pansini F, Perkovic V et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst. Rev. 2009 15 (2 CD007784.
16. Todorovic Z, Nesic Z, Stojanović R et al. Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: It is never too late for the pretreatment. J. Pharmacol. Sci. 2008 107 : 465 470.
17. Sharyo S, Yokota-Ikeda N, Mori M et al. Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int. 2008 74 : 577 584.
18. Inman SR, Davis NA, Olson KM, Lukaszek VA. Simvastatin attenuates renal ischemia/reperfusion injury in rats administered cyclosporine A. Am. J. Med. Sci. 2003 326 : 117 121.
19. Gueler F, Rong S, Park JK et al. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J. Am. Soc. Nephrol. 2002 13 : 2288 2298.
20. Khanal S, Attallah N, Smith DE et al. Statin therapy reduces contrast-induced nephropathy: An analysis of contemporary percutaneous interventions. Am. J. Med. 2005 118 : 843 849.
21. Patti G, Nusca A, Chello M et al. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am. J. Cardiol. 2008 101 : 279 285.
22. Jo SH, Koo BK, Park JS et al. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial - a randomized controlled study. Am. Heart J. 2008 155 : 499. e1 8.
23. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J. Am. Coll. Cardiol. 2004 44 : 1393 1399.
24. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat. Med. 1998 17 : 2265 2281.
25. Attallah N, Yassine L, Musial J, Yee J, Fisher K. The potential role of statins in contrast nephropathy. Clin. Nephrol. 2004 62 : 273 278.
26. Zhao JL, Yang YJ, Zhang YH et al. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty. Int. J. Cardiol. 2008 126 : 435 436.
27. Bouzas-Mosquera A, Vázquez-Rodríguez JM, Calviño-Santos R, Vázquez-González N, Castro-Beiras A. Statin therapy and contrast-induced nephropathy after primary angioplasty. Int. J. Cardiol. 2008 doi: 10.1016/j.ijcard.2007.12.122. (Accessed 03/24/2009).
28. Mehta RL, Pascual MT, Gruta CG et al. Refining predictive models in critically ill patients with acute renal failure. J. Am. Soc. Nephrol. 2002 13 : 1350 1357.
29. Thakar CV, Arrigain S, Worley S et al. A clinical score to predict acute renal failure after cardiac surgery. J. Am. Soc. Nephrol. 2005 16 : 162 168.
30. Greene T. Randomized and observational studies in nephrology: How strong is the evidence? Am. J. Kidney Dis. 2009 53 : 377 388.